相关实验视频

Updated: May 6, 2026

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

青少年的代谢和减肥手术结果:单一中心的七年更新

Michael Kochis¹, Christa Bizimana², Alyssa Stetson²

¹Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. mkochis@mgh.harvard.edu.

Surgical endoscopy

|September 24, 2024

概括

代谢和减肥手术 (MBS) 对严重肥胖的青少年来说是安全有效的. 袖子胃切除术 (LSG) 现在比胃绕道术 (LRYGB) 更常见,显示出显著的体重减轻和并发症改善.

科学领域:

青少年健康青少年健康
外科手术的结果
肥胖管理肥胖管理

背景情况:

代谢和减肥手术 (MBS) 是一种越来越多地用于治疗青少年严重肥胖的治疗方法.
最近的趋势表明,患者人群更加多样化,并且从腹腔镜Roux-en-Y胃绕道 (LRYGB) 转向袖子胃切除术 (LSG).

研究的目的:

评估青少年和年轻人的MBS结果,重点关注随访时间,体重减轻,并发症解决和并发症.
更新该机构以前的调查结果,并反映青少年MBS的当前国家趋势.

主要方法:

在2014年至2020年期间接受MBS的21岁以下患者的回顾性队列分析.
通过图表审查收集的数据包括人口统计,并发症,BMI,在各种时间点的百分比总体体重减轻 (%TBWL) 和并发症.
用回归分析来检查术前因素,随访和%TBWL之间的关联.

主要成果:

该研究包括79名患者,其中73%为女性,具有多种种族/种族背景 (53%为白人,24%为西班牙裔,15%为非西班牙裔黑人).
80%的患者接受了LSG,在3.0年的随访期中,TBWL的中位数为23%. 在2.4年内,LRYGB患者达到28%%TBWL.
57%的术前并发症患者在手术后出现改善. 发生了三次30天的 readmissions,没有死亡.

结论:

在患有严重肥胖的青少年中,MBS,特别是LSG,是减肥和并发症解决的安全有效选择.
这些发现与国家趋势一致,表明患者群体的多样性越来越大,并且人们更喜欢LSG.

关键词:

青少年青少年青少年伴随性疾病伴随性疾病腹腔镜外套胃切除术腹腔镜外套胃切除术代谢和减肥手术的代谢和减肥手术.在Roux-en-Y的胃旁路术中.减肥的方法减肥的方法减肥的方法

更多相关视频

A Murine Model of Vertical Sleeve Gastrectomy

A Murine Model of Vertical Sleeve Gastrectomy

Published on: December 18, 2017

Sleeve Gastrectomy in Mice using Surgical Clips

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

相关概念视频

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...